An FDA Q&A: How Does The First Amendment Limit Its Regulatory Power?

By Alan R. Bennett, a partner in the Washington, D.C. office of the law firm Ropes & Gray, and Kenneth P. Berkowitz, President of KPB Associates, a Washington, D.C. consulting firm specializing in the regulation of medical communications.